Comprehensive Analysis of Key Genes and Pathways for Biological and Clinical Implications in Thyroid-associated Ophthalmopathy

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2022 Sep 2

PMID 36056316

Authors

Yueyue Wang

Yanfei Shao

Haitao Zhang

Jun Wang

Peng Zhang

Weizhong Zhang

Huanhuan Chen

Affiliations

Soon will be listed here.

Abstract

Background: Thyroid-associated ophthalmopathy (TAO) is a common and organ-specific autoimmune disease. Early diagnosis and novel treatments are essential to improve the prognosis of TAO patients. Therefore, the current work was performed to identify the key genes and pathways for the biological and clinical implications of TAO through comprehensive bioinformatics analysis and a series of clinical validations.

Methods: GSE105149 and GSE185952 were obtained from the Gene Expression Omnibus (GEO) database for analysis. The data were normalized to identify the common differentially expressed genes (DEGs) between the two datasets, and the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted to assess key pathways in TAO. Protein-protein interaction (PPI) networks and hub genes among the common DEGs were identified. Furthermore, we collected the general information and blood samples from 50 TAO patients and 20 healthy controls (HCs), and the expression levels of the proteins encoded by hub genes in serum were detected by enzyme-linked immunosorbent assay (ELISA). Then we further assessed the relationship between the ELISA data and the TAO development.

Results: Several common pathways, including neuroactive ligand-receptor interaction, the IL-17 signaling pathway, and the TNF signaling pathway, were identified in both datasets. In parallel, 52 common DEGs were identified. The KEGG analysis showed that these common DEGs are mainly enriched in long-term depression, the VEGF signaling pathway, the IL-17 signaling pathway, the TNF signaling pathway, and cytokine-cytokine receptor interactions. The key hub genes PRKCG, OSM, DPP4, LRRTM1, CXCL6, and CSF3R were screened out through the PPI network. As confirmation, the ELISA results indicated that protein expression levels of PRKCG, OSM, CSF3R, and DPP4 were significantly upregulated in TAO patients compared with HCs. In addition, PRKCG and DPP4 were verified to show value in diagnosing TAO, and CSF3R was found to be a valuable diagnostic marker in distinguishing active TAO from inactive TAO.

Conclusions: Inflammation- and neuromodulation-related pathways might be closely associated with TAO. Based on the clinical verification, OSM, CSF3R, CXCL6, DPP4, and PRKCG may serve as inflammation- or neuromodulation-related biomarkers for TAO, providing novel insights for the diagnosis and treatment of TAO.

Citing Articles

Identification and verification of the optimal feature genes of ferroptosis in thyroid-associated orbitopathy.

Li X, Xiong C, Wang S, Ren Z, Jin Q, Yu J Front Immunol. 2024; 15:1422497.

PMID: 39735537 PMC: 11671519. DOI: 10.3389/fimmu.2024.1422497.

Psychological aspects of Graves' ophthalmopathy.

Al-Badri W, Jellema H, Potvin A, van Nispen R, Bisschop P, Saeed P Endocr Connect. 2024; 13(9).

PMID: 39032509 PMC: 11378138. DOI: 10.1530/EC-24-0259.

A comprehensive epigenetic network can influence the occurrence of thyroid-associated ophthalmopathy by affecting immune and inflammatory response.

Zhang Z, Wu H, Gong X, Yan Y, Li X, Yang R Sci Rep. 2024; 14(1):13545.

PMID: 38867076 PMC: 11169257. DOI: 10.1038/s41598-024-64415-8.

Identification of a diagnostic model and molecular subtypes of major depressive disorder based on endoplasmic reticulum stress-related genes.

Huang S, Li Y, Shen J, Liang W, Li C Front Psychiatry. 2023; 14:1168516.

PMID: 37649561 PMC: 10464956. DOI: 10.3389/fpsyt.2023.1168516.

The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves' disease.

Chang X, Ding X, Wang J, Cai Q, Wang G, Liu J Ann Med. 2023; 55(1):2226910.

PMID: 37350750 PMC: 10291917. DOI: 10.1080/07853890.2023.2226910.

References

Engvall E, Perlmann P . Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972; 109(1):129-35. View

Wang S, Zhang Y, Shi H . Potential Repressive Impact of microRNA-20a on Renal Tubular Damage in Diabetic Kidney Disease by Targeting C-X-C Motif Chemokine Ligand 6. Arch Med Res. 2020; 52(1):58-68. DOI: 10.1016/j.arcmed.2020.08.005. View

Farid M, Roch-Levecq A, Levi L, Brody B, Granet D, Kikkawa D . Psychological disturbance in graves ophthalmopathy. Arch Ophthalmol. 2005; 123(4):491-6. DOI: 10.1001/archopht.123.4.491. View

Fang S, Huang Y, Zhong S, Zhang Y, Liu X, Wang Y . IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy. Invest Ophthalmol Vis Sci. 2016; 57(14):6123-6133. DOI: 10.1167/iovs.16-20199. View

Antonelli A, Ferrari S, Fallahi P, Frascerra S, Santini E, Sellari Franceschini S . Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab. 2009; 94(5):1803-9. DOI: 10.1210/jc.2008-2450. View

Bartalena L, Kahaly G, Baldeschi L, Dayan C, Eckstein A, Marcocci C . The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol. 2021; 185(4):G43-G67. DOI: 10.1530/EJE-21-0479. View

Boboridis K, Bunce C . Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev. 2011; (12):CD007630. DOI: 10.1002/14651858.CD007630.pub2. View

Jiang L, Rong A, Wei R, Diao J, Ding H, Wang W . Tear proteomics of orbital decompression for disfiguring exophthalmos in inactive thyroid-associated ophthalmopathy. Exp Ther Med. 2020; 20(6):253. PMC: 7654220. DOI: 10.3892/etm.2020.9383. View

Chen X, Sun L, Zhao Y . NCMCMDA: miRNA-disease association prediction through neighborhood constraint matrix completion. Brief Bioinform. 2020; 22(1):485-496. DOI: 10.1093/bib/bbz159. View

10.

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

11.

Buccitelli C, Selbach M . mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020; 21(10):630-644. DOI: 10.1038/s41576-020-0258-4. View

12.

Bartley G, Gorman C . Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol. 1995; 119(6):792-5. DOI: 10.1016/s0002-9394(14)72787-4. View

13.

Sheng N, Cui H, Zhang T, Xuan P . Attentional multi-level representation encoding based on convolutional and variance autoencoders for lncRNA-disease association prediction. Brief Bioinform. 2020; 22(3). DOI: 10.1093/bib/bbaa067. View

14.

Tu W, Yao J, Mei Z, Jiang X, Shi Y . Microarray Data of Lacrimal Gland Implicates Dysregulated Protein Processing in Endoplasmic Reticulum in Graves' Ophthalmopathy. Front Endocrinol (Lausanne). 2021; 11:571151. PMC: 7888479. DOI: 10.3389/fendo.2020.571151. View

15.

Zang S, Ponto K, Kahaly G . Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab. 2011; 96(2):320-32. DOI: 10.1210/jc.2010-1962. View

16.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

17.

Grenier A, Dehoux M, Boutten A, Durand G, Gougerot-Pocidalo M, Chollet-Martin S . Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood. 1999; 93(4):1413-21. View

18.

Ayabe R, Rootman D, Hwang C, Ben-Artzi A, Goldberg R . Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2014; 30(5):415-9. DOI: 10.1097/IOP.0000000000000211. View

19.

Chen B, Tsui S, Smith T . IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol. 2005; 175(2):1310-9. DOI: 10.4049/jimmunol.175.2.1310. View

20.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View